BTMD - biote Corp.
1.32
-0.030 -2.273%
Share volume: 265,480
Last Updated: 03-27-2026
Pharmaceutical Products/Medicinal Chemicals:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$1.35
-0.03
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-10-2024 | 08-09-2024 | 11-12-2024 | 03-14-2025 | 05-09-2025 | 11-07-2025 | 03-13-2026 | |
| Assets | ||||||||
| Total Assets | 160.108 M | 92.900 M | 101.252 M | 122.370 M | 123.379 M | 111.324 M | 107.613 M | |
| Current Assets | 114.361 M | 61.767 M | 69.983 M | 68.127 M | 68.680 M | 57.123 M | 54.670 M | |
| Inventories | 18.917 M | 19.212 M | 16.200 M | 14.845 M | 13.451 M | 16.446 M | 19.064 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 78.787 M | 26.419 M | 38.225 M | 39.342 M | 41.700 M | 28.048 M | 24.123 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 2.191 M | 4.523 M | 5.813 M | 6.973 M | 8.389 M | 10.063 M | 10.753 M | |
| Other Assets | 43.556 M | 26.610 M | 25.456 M | 47.270 M | 46.310 M | 44.138 M | 42.190 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 160.108 M | 92.900 M | 101.252 M | 122.370 M | 123.379 M | 111.324 M | 107.613 M | |
| Total liabilities | 205.008 M | 234.551 M | 228.076 M | 224.570 M | 208.205 M | 176.791 M | 158.010 M | |
| Total current liabilities | 24.057 M | 46.266 M | 46.510 M | 51.514 M | 48.470 M | 56.308 M | 44.991 M | |
| Accounts Payable | 4.196 M | 5.793 M | 4.374 M | 5.813 M | 3.335 M | 4.359 M | 6.826 M | |
| Other liabilities | 74.255 M | 82.832 M | 77.415 M | 70.304 M | 58.438 M | 22.120 M | 11.140 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 105.270 M | 103.909 M | 102.548 M | 101.199 M | 99.847 M | 97.130 M | 100.782 M | |
| Other liabilities | 74.255 M | 82.832 M | 77.415 M | 70.304 M | 58.438 M | 22.120 M | 11.140 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -35.399 M | -143.341 M | -130.342 M | -105.928 M | -89.981 M | -72.751 M | -58.539 M | |
| Common stock | 6.000 K | 4.000 K | 4.000 K | 4.000 K | 4.000 K | 4.000 K | 4.000 K | |
| Retained earnings | -31.303 M | -137.723 M | -124.717 M | -100.297 M | -84.346 M | -63.760 M | -49.549 M |